Eurofins Scientific, a provider of biopharma products testing services, has signed an exclusive agreement with Ekkio Capital to acquire the Amatsigroup for approximately $150 million. Amatsigroup is a contract development and manufacturing organization (CDMO) providing preclinical and clinical phase services for the development of human and veterinary drugs. Founded in 2010 by Ekkio Capital, it was formed through the merger of four French companies—Avogadro, Amatsi, DBI and Avepharm—bringing ...